The story of Sildenafil presents a complex case for stakeholders in the pharmaceutical sector. While initially a blockbuster success, creating vast sums, the intellectual property lapse and the subsequent entry of https://viagra577945.getblogs.net/74398474/the-little-copyright-and-big-pharma-a-speculative-bet